Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
apixaban vs rivaroxaban | 0.63 | 0.6 | 9069 | 25 | 23 |
apixaban | 1.61 | 0.5 | 3541 | 80 | 8 |
vs | 1.17 | 0.6 | 8377 | 21 | 2 |
rivaroxaban | 1.37 | 0.7 | 1960 | 22 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
apixaban vs rivaroxaban | 1.01 | 0.6 | 5521 | 14 |
apixaban vs rivaroxaban bleeding risk | 0.41 | 0.8 | 7145 | 71 |
apixaban vs rivaroxaban for dvt | 0.01 | 1 | 5728 | 17 |
apixaban vs rivaroxaban in renal failure | 1.64 | 0.3 | 537 | 69 |
apixaban vs rivaroxaban gi bleed | 1.28 | 0.8 | 4286 | 38 |
apixaban vs rivaroxaban vte | 0.85 | 0.8 | 2016 | 4 |
apixaban vs rivaroxaban trial | 1.05 | 0.8 | 6931 | 82 |
apixaban vs rivaroxaban obesity | 1.41 | 0.1 | 9551 | 72 |
apixaban vs rivaroxaban for afib | 0.55 | 0.4 | 2818 | 85 |
apixaban vs rivaroxaban pulmonary embolism | 1.5 | 0.4 | 4635 | 80 |
apixaban vs rivaroxaban vs dabigatran | 1.63 | 0.7 | 6643 | 90 |
apixaban vs rivaroxaban in renal impairment | 0.23 | 0.9 | 5186 | 73 |
apixaban vs rivaroxaban bleeding | 0.27 | 0.5 | 5562 | 67 |
edoxaban vs apixaban vs rivaroxaban | 1.45 | 1 | 2110 | 84 |